Microbiome’s effect on white matter in autism
Journal of Neurophysiology · 01.04.2025 · 133 (4) · 1150-1158
DOI: 10.1152/jn.00607.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurophysiology, erschienen am 01.04.2025. Verfasst von Katherine Canada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Virginia, Gilmer Hall, Charlottesville, Virginia, United States. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, White Matter, Autism Spectrum Disorder, Brain-Gut Axis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Institute of Mental Health and Neurosciences (NIMHANS).
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is characterized by deficits in social communication and restricted, repetitive behavioral patterns. Although other physiological presentations in individuals with ASD are heterogeneous, neuroimaging studies have consistently revealed a developmental pattern of initial white matter hypermyelination followed by reduced myelination compared with typically developing peers. Multiple studies have demonstrated that core ASD symptoms, including impairments in social skills, language acquisition, learning capabilities, motor performance, and sensory processing, correlate significantly with white matter dysregulation measured through diffusion tensor imaging (DTI). Longitudinal studies have shown that decreased gut microbiome diversity, particularly reductions in beneficial bacteria such as Bifidobacterium and Lactobacillus, correlates with symptom severity. Emerging mechanistic evidence suggests bidirectional relationships between microbiome composition and white matter development, both directly through metabolites like short-chain fatty acids (SCFAs) that regulate oligodendrocyte function and subsequent myelination, and indirectly through modulation of neuroinflammatory pathways. By integrating molecular-level gut physiology findings with macro-level brain imaging data, we may identify novel therapeutic approaches targeting the gut-brain axis in ASD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of Virginia, Gilmer Hall, Charlottesville, Virginia, United States.
- School of Education and Human Development, University of Virginia, Ridley Hall 126, Charlottesville, Virginia, United States.
ORCID-Profile: Katherine Canada
Förderung
- National Institute of Mental Health and Neurosciences (NIMHANS)
Zitieren
APA
Canada, K., Evans, T. M., & Pelphrey, K. A. (2025). Microbiome’s effect on white matter in autism. Journal of Neurophysiology, 133(4), 1150-1158. https://doi.org/10.1152/jn.00607.2024
Vancouver
Canada K, Evans TM, Pelphrey KA. Microbiome’s effect on white matter in autism. Journal of Neurophysiology. 2025;133(4):1150-1158. doi:10.1152/jn.00607.2024
BibTeX
@article{Canada2025,
author = {Canada, Katherine and Evans, Tanya M and Pelphrey, Kevin A},
title = {Microbiome’s effect on white matter in autism},
journal = {Journal of Neurophysiology},
year = {2025},
volume = {133},
number = {4},
pages = {1150--1158},
doi = {10.1152/jn.00607.2024}
}
EUVIMED